| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/01/2005 | EP1534861A1 Sirna-mediated gene silencing with viral vectors |
| 06/01/2005 | EP1534859A2 Methods of detecting sequence differences |
| 06/01/2005 | EP1534858A2 Methods and compositions for monitoring primer extension and polymorphism detection reactions |
| 06/01/2005 | EP1534855A1 Method and kit for the diagnosis of ulcerative colitis |
| 06/01/2005 | EP1534852A2 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 06/01/2005 | EP1534850A2 Improved compositions and methods for cdna synthesis |
| 06/01/2005 | EP1534849A2 Use of malate dehydrogenase for nadh regeneration |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534846A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 06/01/2005 | EP1534845A1 Generation of recombinant influenza virus using baculovirus delivery vector |
| 06/01/2005 | EP1534844A2 Method for improving corn starch extractability |
| 06/01/2005 | EP1534843A2 Sugar and lipid metabolism regulators in plants iv |
| 06/01/2005 | EP1534842A2 Stress tolerance and delayed senescence in plants |
| 06/01/2005 | EP1534841A2 Novel bacterial expression system |
| 06/01/2005 | EP1534840A2 Novel sirna gene libraries and methods for their production and use |
| 06/01/2005 | EP1534839A1 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |
| 06/01/2005 | EP1534838A2 Transgenic bioluminescent plants |
| 06/01/2005 | EP1534837A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 06/01/2005 | EP1534836A1 Mutant forms of meningococcal adp-ribosylating toxin |
| 06/01/2005 | EP1534835A1 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same |
| 06/01/2005 | EP1534834A2 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 06/01/2005 | EP1534833A1 Mammalian grainyhead transcription factors |
| 06/01/2005 | EP1534832A2 Compositions and methods for tissue specific or inducible inhibition of gene expression |
| 06/01/2005 | EP1534830A1 In vitro peptide expression libraray |
| 06/01/2005 | EP1534829A2 Plant defensins |
| 06/01/2005 | EP1534828A2 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes |
| 06/01/2005 | EP1534826A2 Transgenic rat and the use thereof in the animal model for human huntingdon's disease and nuclear constructs, vectors and cells for the production thereof |
| 06/01/2005 | EP1534819A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 06/01/2005 | EP1534756A1 Expression of hydrophobic proteins |
| 06/01/2005 | EP1534749A2 Variant integrin polypeptides and uses thereof |
| 06/01/2005 | EP1534748A2 Fusion proteins and methods of producing same |
| 06/01/2005 | EP1534747A2 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/01/2005 | EP1534745A2 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 06/01/2005 | EP1534739A2 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 06/01/2005 | EP1534738A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/01/2005 | EP1534736A2 Nogo receptor antagonists |
| 06/01/2005 | EP1534735A1 Coded nucleic acid carriers |
| 06/01/2005 | EP1534731A1 Bmp-2 estrogen responsive element and methods of using the same |
| 06/01/2005 | EP1534730A2 Modified transferin-antibody fusion proteins |
| 06/01/2005 | EP1534728A2 Antisense modulation of glucocorticoid receptor expression |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534420A1 High density arrays |
| 06/01/2005 | EP1534332A2 Antibodies and uses thereof |
| 06/01/2005 | EP1534331A2 Membrane associated tumor endothelium markers |
| 06/01/2005 | EP1534328A2 Protective antigens for the control of ixodes species infestations |
| 06/01/2005 | EP1534327A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 06/01/2005 | EP1534325A2 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534308A2 Peptides with growth inhibitory action |
| 06/01/2005 | EP1534306A2 Defensins: use as antiviral agents |
| 06/01/2005 | EP1534264A2 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 06/01/2005 | EP1534073A2 Methods for identifying modulators of mda-7 mediated apoptosis |
| 06/01/2005 | EP1534066A2 Alpha(1,3)-galactosyltransferase null cells, methods of selecting and alpha(1,3)-galactosyltransferase null swine produced therefrom |
| 06/01/2005 | EP1534065A2 Method of selecting cells for somatic cell nuclear transfer |
| 06/01/2005 | EP1534064A2 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 06/01/2005 | EP1490509A4 Modulating insulin receptor signaling |
| 06/01/2005 | EP1451291A4 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
| 06/01/2005 | EP1448794A4 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 06/01/2005 | EP1421203A4 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
| 06/01/2005 | EP1343869A4 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 06/01/2005 | EP1339747B1 Membrane fusion proteins derived from reovirus |
| 06/01/2005 | EP1328663A4 Assays for identifying receptors having alterations in signaling |
| 06/01/2005 | EP1319074B1 Process for producing peptides by using i in vitro /i transcription/translation system |
| 06/01/2005 | EP1311162B1 Bacillus thurigiensis crystal protein hybrids |
| 06/01/2005 | EP1290219B1 Improved invasion assay |
| 06/01/2005 | EP1254179A4 An in vivo screen using chemical inducers of dimerization |
| 06/01/2005 | EP1169282B1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 06/01/2005 | EP1141321B1 Phenol oxidizing enzymes from fungi |
| 06/01/2005 | EP1124838B1 Nucleic acid labeling compounds |
| 06/01/2005 | EP1117478B1 Support for a method for determining an analyte and a method for producing the support |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 06/01/2005 | EP1066376B1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
| 06/01/2005 | EP1047710B1 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
| 06/01/2005 | EP1042460B1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 06/01/2005 | EP0909327B1 Erythromycins and process for their preparation |
| 06/01/2005 | EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells |
| 06/01/2005 | EP0816501B1 Dna encoding protein kinase |
| 06/01/2005 | EP0804559B1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 06/01/2005 | EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells |
| 06/01/2005 | EP0792358B1 A polynucleotide tuberculosis vaccine |
| 06/01/2005 | EP0787189B1 Nucleotide sequences mediating male fertility and method of using same |
| 06/01/2005 | EP0769059B1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/01/2005 | EP0656941B1 Methods for producing members of specific binding pairs |
| 06/01/2005 | CN1623091A Method for analyzing mass spectra |
| 06/01/2005 | CN1623002A Methods of quantitative detection of genetic recombinants and standard molecules for the methods |
| 06/01/2005 | CN1622999A Method for selecting genetically transformed cells |
| 06/01/2005 | CN1622998A Fungus-origin lysyl oxidases |
| 06/01/2005 | CN1622997A Method for inspecting the genetic susceptibility of Helicobacter Pylorus related gastric carcinoma and the use thereof |
| 06/01/2005 | CN1622996A Synthetic herbicide resistance gene |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622993A Targeted chromosomal mutagenesis using zinc finger nucleases |
| 06/01/2005 | CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 06/01/2005 | CN1622955A Tumor tag and the use thereof |
| 06/01/2005 | CN1622831A Method of promoting nucleic acid transfer |
| 06/01/2005 | CN1622828A Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 06/01/2005 | CN1622825A Thermotolerant phytase for animal feed |
| 06/01/2005 | CN1621527A XJ-160 virus infected genome-wide cDNA clone |